• Patrice Forget, Jose A Aguirre, Ivanka Bencic, Alain Borgeat, Allessandro Cama, Claire Condron, Christina Eintrei, Pilar Eroles, Anil Gupta, Tim G Hales, Daniela Ionescu, Mark Johnson, Pawel Kabata, Iva Kirac, Daqing Ma, Zhirajr Mokini, Jose Luis Guerrero Orriach, Michael Retsky, Sergio Sandrucci, Wiebke Siekmann, Ljilja Štefančić, Gina Votta-Vellis, Cara Connolly, and Donal Buggy.
• Anesthesiology and Perioperative Medicine, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Laarbeeklaan 101, 1090 Brussels, Belgium. forgetpatrice@yahoo.fr.
• Cancers (Basel). 2019 Apr 28; 11 (5).

AbstractThe question of whether anesthetic, analgesic or other perioperative intervention during cancer resection surgery might influence long-term oncologic outcomes has generated much attention over the past 13 years. A wealth of experimental and observational clinical data have been published, but the results of prospective, randomized clinical trials are awaited. The European Union supports a pan-European network of researchers, clinicians and industry partners engaged in this question (COST Action 15204: Euro-Periscope). In this narrative review, members of the Euro-Periscope network briefly summarize the current state of evidence pertaining to the potential effects of the most commonly deployed anesthetic and analgesic techniques and other non-surgical interventions during cancer resection surgery on tumor recurrence or metastasis.

3 keywords...

hide…